STEMPEUTICS RESEARCH PVT LTD

Company Report: India-Regenerative Medicine-Unlisted

15 MAY 2014

www.indiabusinessreports.com

COMPANY BACKGROUND

Beginning
Stempeutics Research is a one of the few companies in
India engaged in development of Regenerative
Medicine. Since its inception in 2006, it has built a
strong pipeline of products, some of which are in
Phase II trials.
Promoted by Karnatakas Manipal Group, which has
interests in education and healthcare, the company
has facilities in Bangalore and Manipal (India) as well
as in Kuala Lumpur (Malaysia).
Stempeutics strives towards building strong IP
portfolio and is proactively engaged in extensive
research in the area of stem cell technology and its
application. To build a strong patent portfolio, we seek
patent protection for our innovations at national and
international levels.
Stempeutics has been granted two patents in India
and one patent in South Africa. Stempeutics has filed 9
patents in India, 2 patents in US, 9 patents in Malaysia
and 14 patents across various countries around the
globe
XXXXXXXXXXXXx





XXXXXXXXXXXXXxx





Board of Directors
Name Designation
Hebri Sudarshan Ballal Chairman
Manohar BN MD
Chandrasekaran Madhavan Director
Geena Vinod Malhotra Director
Jaydeep Ashok Gogtay Director
Ranjan Pai Director



Address

Akshay Tech Park, #72 & 73,
2nd Floor , EPIP Zone,
Phase I-Area Whitefield,
Bangalore, Karnataka -
560066

Financial Summary
Year ending June 30
FY11 FY12 FY13
Net Sales (Rs mn)

EBITDA (Rs mn)

EBITDA Margin (%)

PAT (Rs mn)

Net worth (Rs mn)

Debt (Rs mn)


Sales Growth (%)

PAT Growth (%)

ROE (%)

ROCE (%)

D/E (x)


Name of Auditors
SRIRAMULU NAIDU & CO
India-Regenerative Med-Unlisted Stempeutics Research
15 May14
www.indiabusinessreports.com 2



Promoters

Stemeutics is promoted by the Manipal Group, which
has interests in healthcare and education. Cipla

Name No of Shares (%)
Ranjan Pai

MNI Ventures

Meditab Specialities Pvt Ltd
Manipal Education and Medical
Group India Pvt Ltd

Total 3,06,24,644 100.0%
As of Sep13



BUSINESS HIGHLIGHTS

XXXXXXXXX









XXXXXXXXX






XXXXXXXXX






XXXXXXXXX





MANUFACTURING FACILITIES

XXXXXXXXX




XXXXXXXXX




XXXXXXXXX






PEERS

XXXXXXXXX









XXXXXXXXX





India-Regenerative Med-Unlisted Stempeutics Research
15 May14
www.indiabusinessreports.com 3




XXXXXXXXX










FINANCIAL PERFORMANCE

XXXXXXXXX



XXXXXXXXX




FUNDING AND FUTURE PLANS

XXXXXXXXX










XXXXXXXXX





XXXXXXXXX



.
India-Regenerative Med-Unlisted Stempeutics Research
15 May14
www.indiabusinessreports.com 4


FINANCIAL DETAILS

P&L
(Rs mn) FY09 FY10 FY11 FY12 FY13
Net Sales
EBITDA
Margin (%)
Interest
Other Income
PBDT
Depreciation
Extraordinary Item
PBT
PAT
PAT Margin (%)


Balance Sheet
(Rs mn)
FY11 FY12 FY13
Liabilities

Equity Capital
Reserves
Shareholder Funds
Debt
Deferred tax liability
Other Long Term Lialilites
Total Liabilities


Assets

Fixed Assets (net)
Intangible Assets

Investments
Total Non Current Assets
Inventories
Debtors
Cash
Loans & Advances
Other CA


CL & Provisions
Net Current Assets
Deferred Tax Asset

India-Regenerative Med-Unlisted Stempeutics Research
15 May14
www.indiabusinessreports.com 5

Total Assets


Ratios


FY11 FY12 FY13
Growth (%)

Sales

PBDIT

PBT

PAT


Margins (%)

PBDIT

PAT


Balance Sheet Ratios

ROE (%)

ROCE (%)

D/E (x)







About India Business Reports

India Business Reports (IBR) is an initiative of experienced professionals with comprehensive experience across wide domains Research, Investment Banking,
Private Equity Funding, Consulting, Branding and Marketing. The single minded objective at IBR is to generate insightful reports based on hard facts. Our endeavour
is to search for a Big Idea, among seemingly un-connected data points, which has significant strategic relevance. So be it India entry strategies, growth strategies,
M&A opportunities or private equity investments, our reports can become a powerful tool in many ways.

Our content and expertise is relevant not only for the financial fraternity, but also global MNCs looking to do business with India, and Indian companies looking to
fine tune their growth strategies.


Disclaimer

This note is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its
accuracy or completeness guaranteed. The content in this note is solely for informational purpose and is not a solicitation of offer to buy or sell or subscribe for
securities or other financial instruments. Nothing in this note constitutes investment, legal, accounting and tax advice. India Business Reports or its owner-partners
accept no liabilities for any loss or damage of any kind arising out of the use of this note.

Contact
Reports@indiabusinessreports.com